These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25668830)

  • 21. [Validation of a screening method for occupational bladder cancer].
    Borchini R; Bonzini M; Veronesi G; Fava C; Carenzi MC; Mombelli S; Marconi A; Bono AV; Ferrario MM
    Med Lav; 2009; 100(6):438-47. PubMed ID: 20359136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors Associated with Urothelial Bladder Cancer.
    Alouini S
    Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case-control study for the recognition of nonoccupational risk factors for tumors of the lower urinary tract].
    Jarrar K; Johansson B; Bolm-Audorff U; Woitowitz HJ; Weidner W
    Dtsch Med Wochenschr; 1996 Mar; 121(11):325-30. PubMed ID: 8681721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumors of the urinary bladder: an analysis of the occupations of 1,030 patients in Leeds, England.
    Anthony HM; Thomas GM
    J Natl Cancer Inst; 1970 Nov; 45(5):879-95. PubMed ID: 18605414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder Cancer Working Group report.
    Kakehi Y; Hirao Y; Kim WJ; Ozono S; Masumori N; Miyanaga N; Nasu Y; Yokomizo A
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i57-64. PubMed ID: 20870921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occupational exposure to solvents and gasoline and risk of cancers in the urinary tract among Finnish workers.
    Lohi J; Kyyrönen P; Kauppinen T; Kujala V; Pukkala E
    Am J Ind Med; 2008 Sep; 51(9):668-72. PubMed ID: 18561141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and etiology of bladder cancer.
    Cohen SM; Johansson SL
    Urol Clin North Am; 1992 Aug; 19(3):421-8. PubMed ID: 1636227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of bladder cancer.
    Silverman DT; Hartge P; Morrison AS; Devesa SS
    Hematol Oncol Clin North Am; 1992 Feb; 6(1):1-30. PubMed ID: 1556044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces.
    Ugnat AM; Luo W; Semenciw R; Mao Y;
    Chronic Dis Can; 2004; 25(2):7-15. PubMed ID: 15554606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility study for interspecialistic collaboration in active research of urothelial neoplasms of professional origin.
    Stopponi R; Caraceni E; Marronaro A; Fabiani A; Massacesi S; Totò AR; Calisti R
    Arch Ital Urol Androl; 2018 Sep; 90(3):176-180. PubMed ID: 30362683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Uroepithelial tumors of the upper urinary tract following bladder cancer].
    Shinka T; Morimoto S; Uekado Y; Yoshida T; Kumeda K; Hirano A; Komura T; Watanabe T; Ohkawa T
    Hinyokika Kiyo; 1987 Jun; 33(6):844-51. PubMed ID: 3673836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal aspects of bladder carcinogenesis.
    Vineis P; Estève J
    Toxicol Pathol; 1987; 15(2):234-7. PubMed ID: 3616408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder cancer clusters in Florida: identifying populations at risk.
    Nieder AM; MacKinnon JA; Fleming LE; Kearney G; Hu JJ; Sherman RL; Huang Y; Lee DJ
    J Urol; 2009 Jul; 182(1):46-50; discussion 51. PubMed ID: 19450849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transitional bladder cancer and occupational exposure. Accuracy assessment of a screening method based on structured interview].
    Borchini R; Veronesi G; Mombelli S; Fava C; Ferrario MM
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):315-7. PubMed ID: 18409703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.
    Karagas MR; Park S; Warren A; Hamilton J; Nelson HH; Mott LA; Kelsey KT
    Cancer Lett; 2005 Feb; 219(1):63-9. PubMed ID: 15694665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceptions of the causes of bladder cancer, nasal cancer, and mesothelioma among cases and population controls.
    Teschke K; van Zwieten L
    Appl Occup Environ Hyg; 1999 Dec; 14(12):819-26. PubMed ID: 10633953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade.
    Salem HK; Mahfouz S
    Urology; 2012 Feb; 79(2):379-83. PubMed ID: 22112287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.